Corentec Co

Corentec Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Corentec Co (104540.KQ) as of Nov 6, 2026 is 422.67 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 255.55 % — a change of 65.40% (higher).

Cash Conversion

422.67 %

YoY

65.40%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Corentec Co is 2025 422.67 % . Cash Conversion Rate (OCF/Net Income) of Corentec Co was 2024 255.55 % . It decreases by 65.40% higher compared to the previous year.

The Corentec Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
-17.67 KRW
Jan 1, 2019
153.87 KRW
Jan 1, 2020
-229.18 KRW
Jan 1, 2021
533.51 KRW
Jan 1, 2022
595.18 KRW
Jan 1, 2023
64.96 KRW
Jan 1, 2024
255.55 KRW
Jan 1, 2025
422.67 KRW
The Corentec Co Cash Conversion history
YEARCash ConversionYoY
422.67 %+65.40%
255.55 %+293.41%
64.96 %-89.09%
595.18 %+11.56%
533.51 %-332.80%
-229.18 %-248.95%
153.87 %-970.80%
-17.67 %-77.76%
-79.45 %-112.59%
631.02 %-313.13%
-296.08 %+863.42%
-30.73 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Cash Conversion Rate (OCF/Net Income) of Corentec Co is 422.67 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Corentec Co changed from 255.55 % to 422.67 %, representing a 65.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Corentec Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Corentec Co

All Key Metrics — Corentec Co